PRESS RELEASE published on 05/10/2024 at 18:00, 11 months 2 days ago Informations privilégiées / Autres communiqués Annonce mensuelle des actions et droits de vote de Medincell sur Euronext Paris. Medincell développe des médicaments injectables à action prolongée pour divers domaines thérapeutiques Euronext Paris AMF Biopharmaceutique Medincell Médicaments Injectables
BRIEF published on 05/08/2024 at 12:35, 11 months 5 days ago Positive Results for the SOLARIS Phase 3 Trial of Olanzapine Schizophrenia Medincell SOLARIS Olanzapine TEV-'749
BRIEF published on 05/08/2024 at 12:35, 11 months 5 days ago Résultats Positifs pour l'Essai Phase 3 SOLARIS sur l’Olanzapine Schizophrénie Medincell TEV-‘749 SOLARIS Olanzapine
PRESS RELEASE published on 05/08/2024 at 12:30, 11 months 5 days ago Inside Information / Other news releases Teva and Medincell announce positive Phase 3 efficacy results from SOLARIS trial evaluating TEV-'749 (olanzapine) as a once-monthly subcutaneous long-acting injectable in adults with schizophrenia Schizophrenia Medincell Teva Phase 3 Efficacy Results SOLARIS Trial
PRESS RELEASE published on 05/08/2024 at 12:30, 11 months 5 days ago Informations privilégiées / Autres communiqués Les résultats positifs de l'étude de phase 3 SOLARIS démontrent l'efficacité de TV-749, injection sous-cutanée mensuelle pour la schizophrénie par Teva et Medincell Santé Mentale Schizophrénie Medincell TV-749 Teva
BRIEF published on 05/08/2024 at 09:05, 11 months 5 days ago Medincell suspend temporairement sa cotation sur Euronext Paris Euronext Paris Marchés Financiers Communiqué De Presse Médine Partager La Suspension
BRIEF published on 05/08/2024 at 09:05, 11 months 5 days ago Medincell Temporarily Suspends its Euronext Paris Listing Euronext Paris Press Release Financial Markets Medincell Share Suspension
PRESS RELEASE published on 05/08/2024 at 09:00, 11 months 5 days ago Informations privilégiées / Autres communiqués Medincell suspend la cotation de ses actions sur Euronext Paris, en attente de la publication d'un communiqué. Reprise des négociations prévue demain Euronext Paris Cotation Suspension Medincell Communiqué
PRESS RELEASE published on 05/08/2024 at 09:00, 11 months 5 days ago Inside Information / Other news releases Medincell suspends listing of shares on Euronext Paris pending press release. Innovative biopharmaceutical company developing long-acting injectable drugs Euronext Paris Biopharmaceutical Suspension Medincell Long-acting Injectable Drugs
Published on 04/12/2025 at 15:45, 23 hours 32 minutes ago New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CFO Julia Qian, BIOVie’s Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice Presid
Published on 04/12/2025 at 02:00, 1 day 13 hours ago Battery X Metals Announces Provisional Patent Application with United States Patent & Trademark Office for Lithium-Ion Battery Rebalancing Technology Innovations
Published on 04/12/2025 at 00:10, 1 day 15 hours ago Applied Minerals, Inc. Files Motion to Approve Disclosure Statement
Published on 04/11/2025 at 23:45, 1 day 15 hours ago Gold Terra Closes First Tranche of Financing Package with Support from Osisko Gold Royalties
Published on 04/11/2025 at 21:45, 1 day 17 hours ago OPPO Unveils Agentic AI Initiative at Google Cloud Next 2025, Showcasing Innovations and Leadership in AI Experiences
Published on 04/11/2025 at 18:38, 1 day 20 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/11/2025 at 18:23, 1 day 20 hours ago EQS-Adhoc: Cherry SE: Cherry SE recognizes asset impairment for 2024; updates adjusted EBITDA margin for fiscal year 2024
Published on 04/11/2025 at 18:30, 1 day 20 hours ago Reclassification of shares within the Feuillet family concert with no impact on the control of the company
Published on 04/11/2025 at 18:30, 1 day 20 hours ago Reclassement d'actions au sein du concert familial Feuillet sans incidence sur le contrôle de la société
Published on 04/11/2025 at 18:00, 1 day 21 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2025
Published on 04/11/2025 at 18:00, 1 day 21 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2025
Published on 04/11/2025 at 17:50, 1 day 21 hours ago Mise à disposition du Rapport Financier Annuel 2024
